BCR-ABL driven leukemias (e.g. CML) are known to have upregulation of alt-NHEJ related proteins including DNA Ligase IIIα and PARP (117). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.